SCHEMBL6999301

SCHEMBL6999301

C[C@]12C=CC(=NN)C=C1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12

nearest known ligand 0.76

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 18/20 0.76
CYP3A4 P08684 1/20 0.76
ALDH1A1 P00352 2/20 0.55
LMNA P02545 2/20 0.55
SHBG P04278 2/20 0.55
SERPINA6 P08185 2/20 0.55
MAPK1 P28482 2/20 0.55
HSD17B3 P37058 2/20 0.55
SNCA P37840 2/20 0.55
BLM P54132 2/20 0.55
PMP22 Q01453 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
NPSR1 Q6W5P4 2/20 0.55
HSD17B10 Q99714 2/20 0.55
TSHR P16473 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8071461 1.00 CYP19A1 (0.76) CYP19A1CYP3A4ALDH1A1LMNASHBG
Androstenedone SCHEMBL12430773 0.86 CYP19A1 (1.00) CYP19A1CYP3A4LMNA
Androstenedone SCHEMBL172864 0.86 CYP19A1 (1.00) CYP19A1CYP3A4LMNA
Androstenedone SCHEMBL3758714 0.86 CYP19A1 (1.00) CYP19A1CYP3A4LMNA
Androstenedone SCHEMBL1144460 0.86 CYP19A1 (1.00) CYP19A1CYP3A4LMNA
Androstenedone SCHEMBL14450072 0.86 CYP19A1 (1.00) CYP19A1CYP3A4LMNA
Androstenedone SCHEMBL134061 0.86 CYP19A1 (1.00) CYP19A1CYP3A4LMNA
Androstenedone SCHEMBL27795830 0.86 CYP19A1 (1.00) CYP19A1CYP3A4LMNA
Androstenedone SCHEMBL10597170 0.85 CYP19A1 (0.97) CYP19A1CYP3A4LMNA
SCHEMBL8491921 0.81 CYP19A1 (0.76) CYP19A1CYP3A4ALDH1A1LMNASHBG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0863906-B1 HETEROCYCLIC DIOXETHANE SUBSTRATES, PROCESS FOR THEIR PREPARATION AND THEIR USE ROCHE DIAGNOSTICS GMBH (DE) 2003-02-12 EP disclosed
US-6107036-A Heterocyclic dioxethane substrates, process for their preparation and their use ROCHE DIAGNOSTICS GMBH (DE) 2000-08-22 US disclosed
EP-0863906-A2 HETEROCYCLIC DIOXETHANE SUBSTRATES, PROCESS FOR THEIR PREPARATION AND THEIR USE Roche Diagnostics GmbH (DE) 1998-09-16 EP disclosed
WO-1997014696-A2 HETEROCYCLIC DIOXETHANE SUBSTRATES, PROCESS FOR THEIR PREPARATION AND THEIR USE BOEHRINGER MANNHEIM GMBH (DE) 1997-04-24 WO disclosed